BELITE BIO INC - ADR (BLTE) Stock News

NASDAQ:BLTE - Nasdaq - US07782B1044 - ADR - Currency: USD

62.24 +0.39 (+0.63%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BLTE Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Belite Bio, Inc

Belite Bio to Participate in the BTIG Virtual Biotechnology Conference

26 days ago - By: Belite Bio, Inc

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

26 days ago - By: Belite Bio, Inc

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

3 months ago - By: Benzinga

Earnings Outlook For Belite Bio

6 months ago - By: Belite Bio, Inc

Belite Bio Announces Registered Direct Offering of $15 Million

2 months ago - By: Benzinga - Mentions: DY CRWV WRD AHG ...

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday

2 months ago - By: Belite Bio, Inc

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

2 months ago - By: Belite Bio, Inc

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

2 months ago - By: Virtual Investor Conferences - Mentions: VIOT LSE - HCM ...

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

3 months ago - By: Belite Bio, Inc

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Belite Bio, Inc

Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Virtual Investor Conferences

Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th

3 months ago - By: Belite Bio, Inc

Belite Bio to Participate in Four Upcoming Investor Conferences

3 months ago - By: Belite Bio, Inc

Belite Bio to Participate in Four Upcoming Investor Conferences

3 months ago - By: Virtual Investor Conferences - Mentions: YRD IH VIOT LSE ...

UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

3 months ago - By: Virtual Investor Conferences - Mentions: YRD IH VIOT LSE ...

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

3 months ago - By: Belite Bio, Inc

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

3 months ago - By: Belite Bio, Inc

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

3 months ago - By: Belite Bio, Inc

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

4 months ago - By: Belite Bio, Inc

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

4 months ago - By: Belite Bio, Inc

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

4 months ago - By: Belite Bio, Inc

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

4 months ago - By: Belite Bio, Inc

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

5 months ago - By: Belite Bio, Inc

Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: Belite Bio, Inc

Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: Belite Bio, Inc

Belite Bio to Participate in the Leerink Partners Global Healthcare Conference

5 months ago - By: Belite Bio, Inc

Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects

5 months ago - By: Belite Bio, Inc

Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects

6 months ago - By: Belite Bio, Inc

Belite Bio Announces Registered Direct Offering of $15 Million

8 months ago - By: Lin BioScience, Inc.

Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007

9 months ago - By: Belite Bio, Inc

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

9 months ago - By: Belite Bio, Inc

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update